In order to begin to elucidate the genomic basis of the attenuation of mouse-adapted, poliovirus type 2 strain W-2 (PV2/W-2), we have cloned and sequenced the virus and compared it with the virulent, mouse-adapted PV2/Lansing strain. In addition, we have performed computer-generated comparisons of PV2/W-2 to the non-mouse-adapted, attenuated PV2/Sabin strain to determine whether mutational patterns occur that result in attenuation. The PV2/W-2 genome is 7434 nucleotides in length, which is three bases shorter than PV2/Lansing. The 5' non-coding region of PV2/W-2 is 747 nucleotides in length (compared to 744 in PV2/Lansing) and shares 98.8% identity with PV2/Lansing and 82-3% identity with PV2/Sabin. Overall, the PV2/W-2 polyprotein (2205 amino acids) is two amino acids shorter than that of either PV2/Lansing or PV2/Sabin (2207 amino acids). These contiguous deletions fall within the P3-D region (polymerase). Within these 2205 amino acid residues only 26 differences were observed between PV2/W-2 and PV2/Lansing (98-8% identity), whereas 92 occurred between PV2/W-2 and PV2/Sabin (95-8% identity). The 3' non-coding region of PV2/W-2 is 72 nucleotides in length and shares 100% identity with PV2/Lansing and 98.6% identity with PV2/Sabin. Amino acid changes in the capsid protein region occurred in neutralization sites 1 and 3, areas previously shown to be important for pathogenicity. The cleavage site between non-structural proteins P2-C/P3-A consisted of a glutamine-serine pair, in contrast to other sequenced polioviruses which have a glutamineglycine dipeptide.
Introduction
Determination of genomic regions responsible for various biological phenotypes (e.g. virulence and host range) remains a central question in many virus-host systems. The W-2 strain of poliovirus type 2 (PV2/W-2) represents a particularly attractive virus for such studies in that the virus has been adapted for growth in murine tissues (Koprowski et al., 1951 (Koprowski et al., , 1952 and exhibits the characteristics of attenuated poliovirus strains, including temperature sensitivity (Carp et al., 1963) and a decreased rate of dissemination within the central nervous system (CNS) (Jubelt & Meagher, 1984a, b) . PV2/W-2 rarely causes paralysis in mice (Jubelt & Meagher, 1984a) , but can persist in the CNS of immunosuppressed mice, where accumulated mutations in the virion genome relate to the occurrence of late paralysis (Rozhon et al., 1984) .
In contrast, the Lansing strain of poliovirus type 2 (PV2/Lansing) (Armstrong, 1939 ) displays a virulent phenotype in mice (Sabin, 1950) characteristic of human poliomyelitis (Jubelt et al., 1980a) . PV2/W-2 and PV2/Lansing are the only mouse-adapted poliovirus strains that have been well characterized biologically and, in addition, PV2/Lansing has been cloned and sequenced (Racaniello, 1984; La Monica et al., 1986) . Recombination studies have revealed that the PV2/ Lansing capsid region is necessary for mouse intracerebral neurovirulence when compared with the nonmouse-adapted PV1/Mahoney strain (La Monica et al., 1986; Martin et al., 1988; Murray et al., 1988) . Rather than using host range to analyse the molecular basis for virulence and attenuation, our general strategy is to compare the two mouse-adapted PV2 strains, Lansing and W-2. In the present paper we have determined the complete nucleotide sequence of PV2/W-2 and compared this sequence with that of PV2/Lansing and PV2/ Sabin (a non-mouse-adapted, attenuated virus). These analyses have identified a limited number of nucleotide and amino acid differences between the attenuated and virulent mouse-adapted PV2 strains and suggest future experiments to map definitively the genomic regions controlling virulence.
Methods
Materials. The following reagents were purchased: reverse transcriptase (Seikagaku), actinomycin D (Merck), RNasin (PromegaBiotech), [ct-thio-3sS ]dATP and [ct-32p]dCTP (Amersham), deoxynucleoside and dideoxynucleoside triphosphates (Boehringer), T4 DNA ligase, oligo(dT)12_,s, large (Klenow) fragment of Escherichia coli DNA polymerase I, E. coli DNA polymerase I (holoenzyme), T4 DNA polymerase, RNase H, terminal deoxynucleotidyltransferase, and Cyclone I Biosystem (IBI), restriction endonucleases and universal sequencing primer (New England Biolabs).
Virus and cell culture. PV2/W-2 was obtained from the American Type Culture Collection and was twice plaque-purified in RD cells (Jubelt & Meagher, 1984a) .
Virion RNA. Virus was grown in RD cells and purified in a 20 to 70~ sucrose gradient (Jubelt & Lipton, 1987) , followed by isopycnic centrifugation in caesium sulphate (Ziola & Scraba, 1974) . Virion RNA was extracted from 1 mg of purified virions by phenol-chloroform extraction (Pevear et al., 1987) .
Preparalion of the cDNA clones. Viral RNA was transcribed into cDNA for cloning into pBR322 using the replacement synthesis procedure of Kandolf & Hofschneider (1985) with some modifications, as described previously (Pevear et al., 1988) .
Restriction endonuclease digestion. Recombinant plasmid DNAs were digested with restriction endonucleases according to the manufacturers' instructions. The restriction fragments were sized by agarose gel electrophoresis.
DNA sequencing. Overlapping recombinant cDNA clones p 1308 and p1345 were used to determine the complete nucleotide sequence of PV2/W-2 by the dideoxynucleotide sequencing procedure of Sanger et al. (1977) . Subclones in MI3 mpl8 and mpl9 were generated by the unidirectional deletion of large clones (Dale et al., 1985) . Each base was sequenced an average of 3.5 times to generate unambiguous data and about 50~ of the sequence was confirmed on both DNA strands. Every base was read at least twice to eliminate user entry errors.
Computer analysis of the DNA sequence. All DNA sequence manipulations were performed with the UWGCG and Staden programs of the program library of the University of Wisconsin Genetics Computer Group (Staden, 1980; Devereux et al., 1984) on the Northwestern University VAX 11/780 super.minicomputer.
Results

Analysis of cDNA clones
Synthesized oligo(dC)-tailed ds cDNA to PV2/W-2 RNA was inserted into the PstI site of oligo(dG)-tailed pBR322 for transformation of E. coli DH1 cells by the method of Hanahan (1983) . Tetracyclin-resistant, ampicillin-sensitive colonies were screened for insert size by rapid disruption (Maniatis et al., 1982) followed by agarose gel electrophoresis. Restriction enzyme analysis of the larger clones identified two cDNAs, which together appeared to span the entire PV2/W-2 genome (Fig. 1) . However, upon sequencing, cDNA clone p1308 was found to lack the bases corresponding to the first two uridine residues at the 5' end of the viral RNA genome. Clones p1308 and p1345 were joined in pBR322 at the unique ApaI site. A unique BgllI restriction endonuclease site at position 3795 and the PstI sites introduced into the cDNA during cloning into pBR322 were used for subcloning in M13 mpl8 and mpl9 for generation of single-stranded sequencing templates.
Nucleotide sequence and genome organization
By alignment with the reported sequence of PV2/Lansing (La Monica et al., 1986) , as well as a number of other poliovirus strains, it was clear that p1308 lacked only the first two thymidine residues at the 5' end of the viral genomic cDNA. In order to generate a numbering sequence for the PV2/W-2 genome that was consistent with that of PV2/Lansing, we have included these residues in Fig. 2 . Overall, the organization of the PV2/ W-2 genome was identical to that of PV2/Lansing and was typical of all poliovirus serotypes . The 5' non-coding region of the PV2/W-2 genome was 747 nucleotides in length, making it three bases longer than that of PV2/Lansing (Fig. 2) . By computer-generated alignment of the 5' non-coding regions, the three additional guanosine nucleotides in the PV2/W-2 genome were inserted after positions 351,352 and 366 (Table 1 ). Of the 744 nucleotides which could be aligned, 735 bases were identical between the two viruses (98.8~ identity; Table 1 ). Although the 5' non-coding regions of PV2/W-2 and PV2/Sabin were identical in length, the computer algorithm introduced a total of eight gaps into the sequences to optimize alignment with the reported sequence of PV2/Sabin (Toyoda et al., 1984) . Furthermore, of the remaining 739 nucleotides which did align, 132 differed between these two PV2 strains (82.1 ~ identity; data not shown). The polyprotein coding region of PV2/W-2 began at nucleotide position 748 and extended to position 7362, making it six nucleotides shorter than both PV2/Lansing and PV2/Sabin (Fig. 2) . In both cases, the deletions in PV2/W-2 occurred as contiguous nucleotides between PV2/W-2 positions 6672 and 6673 (region P3-D of the genome). The 3' non-coding regions of all three virus strains were 72 nucleotides in length and displayed striking identity with one another. PV2/W-2 and PV2/ Lansing shared 100% nucleotide identity in their 3' noncoding regions, whereas PV2/Sabin had a single mismatch at PV2/W-2 position 7399 (an A in PV2/W-2 to a G in PV2/Sabin). Including gaps introduced into the alignments by the computer algorithm, only 100 nucleotide differences occurred in the entire genome between PV2/W-2 and PV2/Lansing (98.7 % identity). The length 
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AAG GGU UGG AUA GCA GAC AUC ACU AGU CAG GHG CAA ACC GAA AGA AAC AUC AAU AGA GCG AUG ACU AUU CUU CAG GCG GUC ACC ACA UUU
GCC GCA GUU GCU GGA GUG GUG UAU GUG AUG UAC AAA CUC UUU GCA GGG CAU CAA GGA GCG UAU ACA GGG CUU CCC AAC AAG AGA CCC AAU
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7297 CCA AUC GGA AGA GCU UUA COG CUC CCU GAG UAC UCC ACA UUG UAC CGC CGU UGG CUC GAC UCA UUU UAG UAA CCCUACCUCAGUCGAAUUGGAUU Fig. 2 . The complete nucleotide sequence of the RNA genome of PV2/W-2. Cleavage sites within the polyprotein-coding region are assigned based on the original poliovirus protein sequences . The systematic nomenclature for picornavirus proteins is used (Rueckea & Wimmer, 1984) .
of the PV2/W-2 genome was 7434 nucleotides to the guanosine residue preceding the polyadenylation tract at the 3' end of the RNA (Fig. 2) .
Deduced amino acid sequence of the polyprotein coding region
The deduced amino acid sequence of PV2/W-2 was 2205 residues in length, making it two amino acids shorter than PV2/Lansing and PV2/Sabin. As shown in Table 2 only 26 other amino acids differed between PV2/W-2 and PV2/Lansing (98-7~ amino acid identity). Based on the high degree of amino acid identity between PV2/W-2 and PV2/Lansing, the location of their polyprotein cleavage sites is likely to be identical. Although this appears to be the case, the cleavage between P2-C and P3-A, which is carried out by the P3-C protease (Hanecak et al., 1982; Pallansch et al., 1984) , occurred at a glutamine-serine pair in PV2/W-2. This cleavage occurs at a glutamine-glycine pair in all other sequenced polioviruses Emini et aL, 1982; Pallansch et al., 1984; Stanway et al., 1984; Toyoda et al., 1984; La Monica et al., 1986) . Of the 28 amino acid differences between PV2/W-2 and PV2/Lansing, 16 occurred in the capsid protein-coding region (P1) and 12 in the non-structural protein-coding regions (P2 and P3).
As previously mentioned the amino acid deletions in PV2/W-2 occurred in P3-D (polymerase) at PV2/ Lansing amino acid positions 230 and 231 ( Table 2) . As expected from the relatively low degree of nucleotide identity observed in the 5" non-coding regions of PV2/W-2 and PV2/Sabin, a total of 92 amino acid differences were found in the polyproteins in addition to the amino acid deletions in P3-D of PV2/W-2 (95.7~ amino acid identity; Table 2 ). Twenty-three of these differences were located in the major surface capsid protein P1-D (VP1), with 14 falling within 32 amino acid residues of the N terminus of the protein.
Discussion
Determination of genomic regions responsible for various biological phenotypes remains a central question in many virus-host systems. For picornaviruses, the system which has been most extensively studied involves the polioviruses. La Monica et al. (1986) have mapped regions required for neurovirulence within the mouseadapted PV2/Lansing genome using recombinants of PV2/Lansing and the non-mouse-adapted PV1/ Mahoney. They found that a contribution to neurovirulence and attenuation was made not only from the capsid coding region, but also from regions of the genome involved in controlling RNA replication and translation.
More recent studies also demonstrate that attenuating determinants may occur in non-structural protein-coding regions (Kawamura et al., 1989; Moss et al., 1989) . These studies suggest that the ability to replicate in critical tissues (i.e. the host range of the virus) is not in itself sufficient for pathogenesis.
The attenuated PV2/W-2 strain provides an interesting alternative for studying neurovirulence in the apparent absence of a clear contribution from host range limitations. As shown in this report, PV2/Lansing and PV2/W-2 are very closely related genotypically, although PV2/W-2 was not generated from PV2/Lansing (Carp et al., 1963) . There were only 12 non-identical nucleotides occurring in the non-coding regions of the genomes and 28 amino acid differences in the polyproteins (Tables 1  and 2 ). All 12 of the nucleotide changes in the non-coding regions occurred in the 5' untranslated 747 bases. Two specific bases in this region of the PV3 genome have been implicated in neurovirulence, base 472 (Evans et al., 1985) and bases 220 and 472 (La Monica et al., 1987a) . However, there were no nucleotide differences between PV2/Lansing and PV2/W-2 within 80 bases of either of these two sites, indicating that a direct alignment of the PV2 and PV3 genomes would not identify potentially important mutations for attenuation of PV2/W-2.
Sixteen of the amino acid differences in the polyproteins occurred in sequences encoding the capsid proteins of the virus. One of these changes was at VP1 position 99, a Lys in PV2/Lansing to Arg in PV2/W-2, one of the amino acids in neutralization site 1 for PV2/Lansing (Minor et al., 1986; La Monica et al., 1987b) . Antigenic variants of PV2/Lansing with altered neurovirulence display amino acid changes of VP1 residues 93 to 105, with five out of 14 having changes at position 99 (La Monica et al., 1987b) . Insertion of an oligonucleotide cartridge corresponding to amino acids 95 to 102 of PV2/ Lansing into the identical site in PV1/Mahoney (avirulent for mice) resulted in a virus which induced paralytic disease in mice (Martin et al., 1988; Murray et al., 1988) . These studies suggest that changes in neutralization site 1 may alter receptor binding and consequently the pathogenicity of the virus for mice.
A second change occurred at VP1 position 170, in which a Trp in PV2/Lansing was replaced with an Arg in PV2/W-2. Amino acids from VP1 positions 162 to 178 may contribute topographically to neutralization site 1 (Hogle et al., 1985; Minor et aL, 1986) . Although PV2/ W-2 grows to levels comparable to those of PV2/Lansing in the mouse brain after intracerebral inoculation (Jubelt et al., 1980b; Jubelt & Meagher, 1984b) , the attenuated virus displays a limited ability to disseminate (Jubelt & Meagher, 1984a, b) . The onset of flaccid paralysis, characteristic of human poliomyelitis infections, correlates with the involvement of anterior horn cells of the spinal cord, as is seen early in the infectious process of mice with PV2/Lansing and late in infection with PV2/ W-2 of immunosuppressed animals (Jubelt et al., 1980a, b; Jubelt & Meagher, 1984a, b) . Thus, the amino acid substitutions in VP1 at positions 99 and 170 may be influential in the inability of PV2/W-2 to spread to the spinal cord.
Another feature which distinguishes PV2/W-2 and PV2/Lansing is that the former virus induces a brisk neutralizing antibody response, whereas only nonneutralizing antibodies can be identified in PV2/Lansing infection of BALB/c and Swiss mice (Jubelt & Meagher, 1984a; Jubelt et al., 1980a; Jubelt & Lipton, 1987; Miller, 1981) . Neutralization site 1 appears to be the immunodominant site in both PV2/Lansing and PV3/ Sabin (Minor et al., 1986) . Thus, the amino acid substitutions at VP1 residues 99 and 170 may explain the difference in neutralizing antibody responses elicited by these two type 2 polioviruses. Alternatively, the numerous amino acid substitutions in or near neutralization site 3, at amino acids 289, 291,295 and 299 of VP1 and 59 of VP3, may explain the observed difference in neutralizing antibody responses, although site 3 has not been described as an important immunogenic site for type 2 poliovirus (Minor et aL, 1986) .
A role for the non-structural proteins in virulence would appear to be minimized by the observation that inoculation of PV2/W-2 directly into the spinal cord results in paralysis (Jubelt & Meagher, 1984b) . However, overall replication rates of the attenuated virus in the brain do not provide insight into replication rates within tissues that may be critical for spread to the spinal cord. Of particular interest in this context are the changes in the polymerase (P3-D), protease (P3-C) and the P2-C/ P3-A cleavage site. It is quite conceivable that the two contiguous amino acid deletions in the polymerase might ~ffect replication rates in specific tissues. It was surprising to find that the P2-C/P3-A cleavage site in PV2/W-2 occurred at a glutamine-serine pair, as other polioviruses have a glutamine-glycine pair at this location Emini et al., 1982; Pallansch et al., 1984; Stanway et al., 1984; Toyoda et al., 1984; La Monica et aL, 1986) . Other human picornaviruses (coxsackieviruses, hepatitis A virus and rhinoviruses) also have a glutamine-glycine pair at this location (Iizuka et al., 1987; Jenkins et aL, 1987; Lindberg et al., 1987; Cohen et al., 1987; Duechler et al., 1987) . Interestingly, picornaviruses not typically associated with human infections (e.g. encephalomyocarditis virus and Theiler's viruses) have a glutamine-serine cleavage site like PV2/W-2 (Palmenberg et al., 1984; Ohara et aL, 1988; Pevear et al., 1987 Pevear et al., , 1988 . Whether the single amino acid change in the viral protease (P3-C) alters its specificity for this site will be determined.
In summary, we have sequenced the entire genome of the attenuated, mouse-adapted PV2/W-2 strain and identified a limited number of regions within the genome which differ from the neurovirulent PV2/Lansing strain. Similar to the coxsackievirus B3 clone (Kandolf & Hofschneider, 1985) , the PV2/W-2 clone is missing the first two thymidine nucleotides at the 5' end. However, unlike the coxsackievirus B3 clone, the PV2/W-2 cDNA was not infectious in our initial experiments. We are currently engineering a full-length clone of PV2/W-2, complete with the two thymidine residues, in order to confirm the phenotype. Subsequently, we propose to focus entirely on the construction of recombinants between the mouse-adapted strains in order to eliminate the contribution of host range. Recombinants between PV2/W-2 and PV2/Lansing should provide detailed insight into genomic regions important for poliovirus attenuation.
